Company logo
Search
Company logo

Apply

From "Big Pharma" To Pharmacy Benefit Managers: Reforming America’s Broken Drug Pricing System
By Aditi Mudgal, Medical Student at King’s College, London

DOWNLOAD .PDF

The figures are shocking. Nine million adults in the United States of America skipped, rationed, or delayed their medication due to unaffordable drug prices in 2021.1 Prices have continued to soar since, with a 15.2 percent increase in average prices from 2022 to 2023, and 46 percent of price increases being higher than the rate of inflation.2 This essay highlights the need for bipartisan legislative efforts to hold the pharmaceutical industry and powerful middlemen accountable and to provide patients with the transparency and autonomy needed to make empowered decisions about their healthcare. 

From “Big Pharma” to Pharmacy Benefit Managers by Hoover Institution

overlay image